Sinphar Pharmaceutical Co. Ltd.(TW:1734)
NT$30.15+0.05 (+0.17%)
TW:1734
Sinphar Pharmaceutical Co. Ltd. Revenue
NT$30.15
At close:+0.05 (+0.17%)
Sinphar Pharmaceutical Co. Ltd. (1734) Revenue
Sinphar Pharmaceutical Co. Ltd. Revenue
Sinphar Pharmaceutical Co. Ltd. had a revenue of 871.15M in the quarter ending Jun 30, 2026, with 5.39%. This bring the company's revenue in the last twelve months to 3.45B, Increased 1.71%. In the fiscal year ending Dec 31, 2025, Sinphar Pharmaceutical Co. Ltd. had annual revenue of 3.37B with 7.00% growth.
- Revenue (ttm)
- 3.45B
- Revenue Growth
- 2.44%
- P/S Ratio
- 1.80
- Revenue/Employee
- TWD 1,843,259
- Employees
- 1,829
- Market Cap
- TWD 6.07B
Revenue Chart
Sinphar Pharmaceutical Co. Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.37B | 220.69M | 7.00% |
| Dec 31, 2024 | 3.15B | 187.69M | 6.33% |
| Dec 31, 2023 | 2.96B | 106.28M | 3.72% |
| Dec 31, 2022 | 2.86B | 423.13M | 17.39% |
| Dec 31, 2021 | 2.43B | 45.06M | 1.89% |
| Dec 31, 2020 | 2.39B | -6.14M | -0.26% |
| Dec 31, 2019 | 2.39B | 178.75M | 8.07% |
| Dec 31, 2018 | 2.22B | 81.67M | 3.83% |
| Dec 31, 2017 | 2.13B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.